Shares of Gland Pharma gained about 5 percent on February 25, clocking its best day in 16 weeks, ahead of its investor meet on Feb 27-28 during the analyst day with Emkay and BoB Capital.

As a result of these revisions, Nomura has reduced its earnings per share (EPS) forecasts for Gland Pharma for fiscal years 2025, 2026, and 2027 by 4.7%, 4.6%, and 4.0%, respectively. The report ...

Generic injectable-focused Gland Pharma facility in Visakhapatnam has been issued three observations by the U.S. Food and Drug Administration (U.S. FDA). U.S. FDA issues 3 observations to Gland ...

Discover top medications for 'treating Adrenal Gland Disorders'? This page compiles essential information on generic and brand-name drugs specifically used for Adrenal Gland Disorders treatment ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

Searching for effective treatment options for 'Swollen Glands symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...